Hajjar, Roger

Roger Hajjar is currently head of R&D at Flagship Pioneering.

Throughout his career, Dr. Hajjar been at the fore front of cardiac gene therapy having validated validated a number of molecular targets that led to the initiation and completion under his guidance of First-in-Man gene therapy trials in patients with heart failure.

Dr. Hajjar has co-founded several biotechnologies companies in the field of gene therapy.